Quantitative Systems Pharmacology Analysis of KRAS G12C Covalent Inhibitors
Open Access
- 25 March 2018
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 7 (5) , 342-351
Abstract
KRAS has proven difficult to target pharmacologically. Two strategies have recently been described for covalently targeting the most common KRAS mutant in lung cancer, KRAS G12C. Previously, we developed a computational model of the processes that regulate Ras activation. Here, we use this model to investigate KRAS G12C covalent inhibitors. We updated the model to include Ras protein turnover, and validation demonstrates that our model performs well in areas of G12C targeting where conventional wisdom struggles. We then used the model to investigate possible strategies to improve KRAS G12C inhibitors and identified GEF loading as a mechanism that could improve efficacy. Our simulations also found resistance‐promoting mutations may reverse which class of KRAS G12C inhibitor inhibits the system better, suggesting that there may be value to pursuing both types of KRAS G12C inhibitors. Overall, this work demonstrates areas in which systems biology approaches can inform Ras drug development.Keywords
All Related Versions
Funding Information
- Training Program in Immunology and Immunogenetics (5T32AI7163)
This publication has 49 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Ras, an Actor on Many Stages: Posttranslational Modifications, Localization, and Site-Specified EventsGenes & Cancer, 2011
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With CetuximabJAMA, 2010
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBNature Medicine, 2010
- Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic dataMolecular Systems Biology, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Tumour maintenance is mediated by eNOSNature, 2008
- Ligand‐dependent responses of the ErbB signaling network: experimental and modeling analysesMolecular Systems Biology, 2007
- Regulation of Ras Signaling Dynamics by Sos-Mediated Positive FeedbackCurrent Biology, 2006
- Antisense Oligonucleotides Demonstrate a Dominant Role of c-Ki-RAS Proteins in Regulating the Proliferation of Diploid Human FibroblastsJournal of Biological Chemistry, 1996